Table: begin end state 1 32 non-cytoplasmic 33 53 transmembrane 54 59 cytoplasmic 60 81 transmembrane 82 99 non-cytoplasmic 100 121 transmembrane 122 129 cytoplasmic 130 152 transmembrane 153 171 non-cytoplasmic 172 199 transmembrane 200 209 cytoplasmic 210 232 transmembrane 233 277 non-cytoplasmic 278 300 transmembrane 301 319 cytoplasmic 320 340 transmembrane 341 346 non-cytoplasmic 347 388 transmembrane 389 407 non-cytoplasmic 408 438 transmembrane 439 559 cytoplasmic
Input: >15328 FitnessBrowser__Keio:15328 MNKIFSSHVMPFRALIDACWKEKYTAARFTRDLIAGITVGIIAIPLAMALAIGSGVAPQY GLYTAAVAGIVIALTGGSRFSVSGPTAAFVVILYPVSQQFGLAGLLVATLLSGIFLILMG LARFGRLIEYIPVSVTLGFTSGIGITIGTMQIKDFLGLQMAHVPEHYLQKVGALFMALPT INVGDAAIGIVTLGILVFWPRLGIRLPGHLPALLAGCAVMGIVNLLGGHVATIGSQFHYV LADGSQGNGIPQLLPQLVLPWDLPNSEFTLTWDSIRTLLPAAFSMAMLGAIESLLCAVVL DGMTGTKHKANSELVGQGLGNIIAPFFGGITATAAIARSAANVRAGATSPISAVIHSILV ILALLVLAPLLSWLPLSAMAALLLMVAWNMSEAHKVVDLLRHAPKDDIIVMLLCMSLTVL FDMVIAISVGIVLASLLFMRRIARMTRLAPVVVDVPDDVLVLRVIGPLFFAAAEGLFTDL ESRLEGKRIVILKWDAVPVLDAGGLDAFQRFVKRLPEGCELRVCNVEFQPLRTMARAGIQ PIPGRLAFFPNRRAAMADL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server